Wolverine Trading’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,081
Closed -$780K 1494
2025
Q1
$780K Sell
21,081
-28,466
-57% -$1.05M ﹤0.01% 488
2024
Q4
$1.91M Buy
49,547
+33,647
+212% +$1.3M ﹤0.01% 363
2024
Q3
$752K Sell
15,900
-1,579
-9% -$74.7K ﹤0.01% 511
2024
Q2
$944K Sell
17,479
-12,008
-41% -$649K ﹤0.01% 420
2024
Q1
$2.01M Buy
29,487
+9,564
+48% +$652K ﹤0.01% 242
2023
Q4
$1.25M Buy
19,923
+863
+5% +$54K ﹤0.01% 373
2023
Q3
$865K Buy
19,060
+5,059
+36% +$230K ﹤0.01% 393
2023
Q2
$798K Buy
14,001
+9,460
+208% +$539K ﹤0.01% 390
2023
Q1
$201K Sell
4,541
-885
-16% -$39.2K ﹤0.01% 807
2022
Q4
$221K Buy
5,426
+1,754
+48% +$71.4K ﹤0.01% 707
2022
Q3
$237K Sell
3,672
-3,140
-46% -$203K ﹤0.01% 832
2022
Q2
$429K Sell
6,812
-16,224
-70% -$1.02M ﹤0.01% 584
2022
Q1
$1.48M Sell
23,036
-16,150
-41% -$1.03M ﹤0.01% 359
2021
Q4
$3.09M Buy
39,186
+5,858
+18% +$462K ﹤0.01% 252
2021
Q3
$3.67M Sell
33,328
-16,474
-33% -$1.82M ﹤0.01% 245
2021
Q2
$7.5M Sell
49,802
-11,949
-19% -$1.8M 0.01% 109
2021
Q1
$7.11M Buy
61,751
+27,504
+80% +$3.17M 0.01% 122
2020
Q4
$5.53M Buy
34,247
+18,512
+118% +$2.99M 0.01% 130
2020
Q3
$1.34M Sell
15,735
-6,221
-28% -$529K ﹤0.01% 329
2020
Q2
$1.65M Buy
21,956
+4,583
+26% +$344K ﹤0.01% 238
2020
Q1
$769K Buy
17,373
+3,816
+28% +$169K ﹤0.01% 477
2019
Q4
$838K Buy
+13,557
New +$838K ﹤0.01% 704
2019
Q3
Hold
0
1423
2019
Q2
Hold
0
1360
2019
Q1
Hold
0
1368
2018
Q4
Sell
-16,571
Closed -$735K 1441
2018
Q3
$735K Buy
+16,571
New +$735K ﹤0.01% 655